Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 22172430)

1.

Design of the Trial to Assess Chelation Therapy (TACT).

Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Drisko JA, Lee KL.

Am Heart J. 2012 Jan;163(1):7-12. doi: 10.1016/j.ahj.2011.10.002.

2.

Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.

Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT Investigators.

JAMA. 2013 Mar 27;309(12):1241-50. doi: 10.1001/jama.2013.2107.

3.

EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.

Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, Rozema T, Nahin RL, Terry Chappell L, Lindblad L, Lewis EF, Drisko J, Lee KL.

Am Heart J. 2014 Jul;168(1):37-44.e5. doi: 10.1016/j.ahj.2014.02.012. Epub 2014 Apr 2.

4.

The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).

Escolar E, Lamas GA, Mark DB, Boineau R, Goertz C, Rosenberg Y, Nahin RL, Ouyang P, Rozema T, Magaziner A, Nahas R, Lewis EF, Lindblad L, Lee KL.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):15-24. doi: 10.1161/CIRCOUTCOMES.113.000663. Epub 2013 Nov 19.

5.

Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned.

Atwood KC, Woeckner E, Baratz RS, Sampson WI.

Medscape J Med. 2008 May 13;10(5):115.

6.

Letter to the editor concerning article "Design of the Trial to Assess Chelation Therapy (TACT)".

Ernst E.

Am Heart J. 2012 Dec;164(6):e23; author reply e25. doi: 10.1016/j.ahj.2012.07.009. Epub 2012 Oct 31. No abstract available.

PMID:
23194497
7.

Effect of chelation therapy on endothelial function in patients with coronary artery disease: PATCH substudy.

Anderson TJ, Hubacek J, Wyse DG, Knudtson ML.

J Am Coll Cardiol. 2003 Feb 5;41(3):420-5.

PMID:
12575969
8.

Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial.

Lamas GA, Boineau R, Goertz C, Mark DB, Rosenberg Y, Stylianou M, Rozema T, Nahin RL, Lindblad L, Lewis EF, Drisko J, Lee KL; TACT (Trial to Assess Chelation Therapy) Investigators.

Ann Intern Med. 2013 Dec 17;159(12):797-805.

9.

Chelation therapy for ischemic heart disease: a randomized controlled trial.

Knudtson ML, Wyse DG, Galbraith PD, Brant R, Hildebrand K, Paterson D, Richardson D, Burkart C, Burgess E; Program to Assess Alternative Treatment Strategies to Achieve Cardiac Health (PATCH) Investigators.

JAMA. 2002 Jan 23-30;287(4):481-6.

PMID:
11798370
10.

Chelation therapy.

[No authors listed]

Harv Heart Lett. 2002 Apr;12(8):5-7. No abstract available.

PMID:
11959517
11.

Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial.

Mark DB, Anstrom KJ, Clapp-Channing NE, Knight JD, Boineau R, Goertz C, Rozema TC, Liu DM, Nahin RL, Rosenberg Y, Drisko J, Lee KL, Lamas GA; TACT Investigators.

Circ Cardiovasc Qual Outcomes. 2014 Jul;7(4):508-16.

PMID:
24987051
12.

EDTA chelation reappraisal following new clinical trials and regular use in millions of patients: review of preliminary findings and risk/benefit assessment.

Born T, Kontoghiorghe CN, Spyrou A, Kolnagou A, Kontoghiorghes GJ.

Toxicol Mech Methods. 2013 Jan;23(1):11-7. doi: 10.3109/15376516.2012.730562. Epub 2012 Oct 19.

PMID:
22991933
13.

Effect of a multivitamin and mineral supplement on infection and quality of life. A randomized, double-blind, placebo-controlled trial.

Barringer TA, Kirk JK, Santaniello AC, Foley KL, Michielutte R.

Ann Intern Med. 2003 Mar 4;138(5):365-71.

PMID:
12614088
14.

A TACTful reappraisal of chelation therapy in cardiovascular disease.

Sidhu MS, Saour BM, Boden WE.

Nat Rev Cardiol. 2014 Mar;11(3):180-3. doi: 10.1038/nrcardio.2013.176. Epub 2013 Dec 17. Review.

PMID:
24343569
15.

Trial to Assess Chelation Therapy (TACT) and equipoise: When evidence conflicts with beliefs.

Maron DJ, Hlatky MA.

Am Heart J. 2014 Jul;168(1):4-5. doi: 10.1016/j.ahj.2014.03.008. Epub 2014 Apr 2. No abstract available.

PMID:
24952853
17.

Concerns about reliability in the Trial to Assess Chelation Therapy (TACT).

Nissen SE.

JAMA. 2013 Mar 27;309(12):1293-4. doi: 10.1001/jama.2013.2778. No abstract available.

PMID:
23532246
18.

Evaluation of the Trial to Assess Chelation Therapy (TACT): the scientific process, peer review, and editorial scrutiny.

Bauchner H, Fontanarosa PB, Golub RM.

JAMA. 2013 Mar 27;309(12):1291-2. doi: 10.1001/jama.2013.2761. No abstract available.

PMID:
23532245
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk